Renoprotective Effects of SGLT2 Inhibitors in Japanese Real-World Clinical Practice

被引：0
|
作者：
Tosaki, Takahiro
Sato, Shiori Toga
Kondo, Masaki
Yamada, Yuichiro
Inagaki, Akemi
Tsunekawa, Shin
Himeno, Tatsuhito
Kato, Yoshiro
Nakamura, Jiro
Kamiya, Hideki
机构：
来源：
DIABETES | 2019年 / 68卷
关键词：
D O I：
10.2337/db19-2350-PUB
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2350-PUB
引用
下载
收藏
页数：2
相关论文
共 50 条
  • [21] Real-World Safety and Efficacy of SGLT2 Inhibitors in Elderly Type 2 Diabetic Patients
    Trescoli, Carlos
    Fajardo, Carmen
    Aranzo, Jose
    Trescoli, Ana
    Garcia, Mar
    DIABETES, 2016, 65 : A595 - A595
  • [22] Real-World Study on the Effect of SGLT2 Inhibitors in Patients with Type 2 Diabetes in China
    Xue, Yaoming
    Shi, Lixin
    Yu, Xuefeng
    Wang, Yangang
    Hong, Tianpei
    Li, Xiaoying
    Ma, Jianhua
    Zhu, Dalong
    Mu, Yiming
    DIABETES, 2024, 73
  • [23] The major molecular mechanisms mediating the renoprotective effects of SGLT2 inhibitors: An update
    Yaribeygi, Habib
    Simental-Mendia, Luis E.
    Banach, Maciej
    Bo, Simona
    Sahebkar, Amirhossein
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 120
  • [24] Renoprotective effects of GLP1R agonists and SGLT2 inhibitors
    Hocher, Berthold
    Tsuprykov, Oleg
    NATURE REVIEWS NEPHROLOGY, 2017, 13 (12) : 728 - 729
  • [25] Renoprotective effects of GLP1R agonists and SGLT2 inhibitors
    Berthold Hocher
    Oleg Tsuprykov
    Nature Reviews Nephrology, 2017, 13 : 728 - 730
  • [26] SGLT2 inhibitors in the real world: too good to be true?
    Fitchett, David
    LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (09): : 673 - 675
  • [27] Relative and Absolute Risks of Adverse Events with Real-World Use of SGLT2 Inhibitors in CKD
    Odutayo, Ayodele
    Levin, Adeera
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2023, 18 (05): : 557 - 559
  • [28] DIABETIC COMPLICATIONS ASSOCIATED WITH SGLT2 AND DPP4 INHIBITORS: A REAL-WORLD APPROACH
    Kashambwa, R.
    Stapff, M.
    VALUE IN HEALTH, 2019, 22 : S141 - S141
  • [29] GLP1 Receptor Agonist and SGLT2 Inhibitor Combination: An Effective Approach in Real-world Clinical Practice
    Diaz-Trastoy, Olaia
    Villar-Taibo, Rocio
    Sifontes-Dubon, Mildred
    Mozo-Penalver, Hector
    Bernabeu-Moron, Ignacio
    Cabezas-Agricola, Jose M.
    Munoz-Leira, Virginia
    Peino-Garcia, Roberto
    Martis-Sueiro, Aurelio
    Garcia-Lopez, Jose M.
    Martinez-Olmos, Miguel A.
    CLINICAL THERAPEUTICS, 2020, 42 (02) : E1 - E12
  • [30] Cardio-renoprotective effects of SGLT2 inhibitors-the role of anaemia correction
    Locatelli, Francesco
    Del Vecchio, Lucia
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 (06) : 904 - 906
12345